TriSalus Life Sciences, Inc. Income Taxes Paid
TriSalus Life Sciences, Inc. (TLSI) reported Income Taxes Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-06
- TriSalus Life Sciences, Inc. income taxes paid, net for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- TriSalus Life Sciences, Inc. income taxes paid, net for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- TriSalus Life Sciences, Inc. income taxes paid, net for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- TriSalus Life Sciences, Inc. income taxes paid, net for the quarter ending 2025-09-30 was $0.00.
- TriSalus Life Sciences, Inc. income taxes paid, net for fiscal 2025 was $16.00K, a 11.11% decline from fiscal 2024.
- TriSalus Life Sciences, Inc. income taxes paid, net for fiscal 2024 was $18.00K, a 28.57% increase from fiscal 2023.
- TriSalus Life Sciences, Inc. income taxes paid, net for fiscal 2023 was $14.00K, a 55.56% increase from fiscal 2022.
- TriSalus Life Sciences, Inc. income taxes paid, net for fiscal 2022 was $9.00K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month | Income Taxes Paid, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-05-12 | $0.00 derived: sum of 3 quarters · filed 2026-05-12 | $15.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $15.00K derived: sum of 3 quarters · filed 2026-08-06 | $16.00K 10-K · filed 2026-03-05 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $15.00K derived: sum of 2 quarters · filed 2026-08-06 | $16.00K 10-Q · filed 2025-11-13 | $30.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $16.00K 10-Q · filed 2026-08-06 | $30.00K derived: sum of 3 quarters · filed 2026-08-06 | $30.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $1.00K 10-Q · filed 2026-05-12 | $15.00K derived: sum of 2 quarters · filed 2026-05-12 | $15.00K derived: sum of 3 quarters · filed 2026-05-12 | $19.00K derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $14.00K derived: sum of 2 quarters · filed 2026-03-05 | $18.00K derived: sum of 3 quarters · filed 2026-03-05 | $18.00K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $4.00K derived: sum of 2 quarters · filed 2025-11-13 | $4.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $4.00K 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | $14.00K 10-K/A · filed 2025-05-30 | ||||
| 2023-06-30 | $67.00K 10-Q · filed 2023-08-02 | ||||
| 2022-12-31 | -$47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-11 | $9.00K 10-K · filed 2024-04-11 | $543.00K 10-K · filed 2023-03-22 | ||
| 2022-09-30 | $56.00K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |